Frontier investable areas in brain health with PsyMed Ventures

Greg and Matias sit down with Brooks Leitner, the newest venture partner at PsyMed Ventures, to explore the future of brain and mental health investing. Brooks, an MD/PhD with deep experience from Yale and the NIH, shares his insights on how a human-first approach is reshaping neuroscience innovation and venture investing.  In this episode, we discuss:Broadening the Thesis: Evolving from a psychedelics-only focus to a comprehensive neuro investment strategy.Human-First Research: Shifting from animal models to clinical insights for better brain therapies.Key Investment Areas: Therapeutics, medical devices, diagnostics, consumer health, and AI-enabled care platforms.Early-Stage Conviction: Leveraging a prepared mind to spot breakthrough opportunities.Personal & Future Insights: Leadership challenges and the vision for the future of neuro investing. Credits: Created by Greg Kubin and Matias Serebrinsky Host: Matias Serebrinsky & Greg Kubin Produced by Jonathan A. Davis,  Nico V. Rey & Caitlin Ner Find us at businesstrip.fm and psymed.ventures Follow us on Instagram and Twitter! Theme music by Dorian Love Additional Music: Distant Daze by Zack Frank